Springer Medicine

Trustworthy, tailored, cutting-edge content for medical professionals who want to deliver the best possible care. #EdsChoice selections by the content team.

[Springer Medicine @Springer_Med]

Catch up on the latest breakthroughs and top stories from #ESMO2026 with our congress hub.

Stay tuned for expert insights and highlights from across the spectrum of oncology.

👉️ https://t.co/Wd8ic9ySpc

[Springer Medicine @Springer_Med]

Frailty is an important predictor of poor health outcomes in people with rheumatoid arthritis.

Explore current approaches to defining and measuring it in this patient population as well as potential strategies for intervention.

👉 https://t.co/fHN9G4F8eL

#RheumTwitter

[Springer Medicine @Springer_Med]

From #ESMO2026 - Adding tarlatamab to first-line maintenance durvalumab significantly extends the overall survival of patients with extensive-stage small-cell lung cancer and no progression after initial chemoimmunotherapy.

👉 https://t.co/Hv6XrUR2KY

#MedNews

[Springer Medicine @Springer_Med]

A summary of the key #CVD prevention studies presented at #ESCCongress 2026, highlighting new evidence in lipid management, cardiovascular risk assessment, blood pressure control, and prevention of cardiorespiratory complications.

👉 https://t.co/xofskRfhEQ

#CardioTwitter

[Springer Medicine @Springer_Med]

#MedNews - An epidemiologic analysis of a #measles outbreak that led to the loss of measles elimination status in Canada could be used to inform future outbreak control efforts.

Full story 👉 https://t.co/UTegpHUTwQ

#IDMed

[Springer Medicine @Springer_Med]

#MedCase - Severe calcification of a hydrophilic acrylic intraocular lens developed in a patient with end-stage renal disease and longstanding diabetes.

Which IOL materials may help reduce risk in susceptible patients?

👉 https://t.co/dqFZpM9r4H

#EyeMed

[Springer Medicine @Springer_Med]

From #ESMO2026 - Prof. Inge Marie Svane highlights the #melanoma research that caught her attention, from a potentially practice-changing advance with personalized mRNA vaccines to the early promise of tumor-infiltrating lymphocytes.

Full video 👉 https://t.co/98hpFKtkii

[Springer Medicine @Springer_Med]

#MedCase - Penetrating coronary artery ulcers are exceptionally rare.

This case details the presentation, angiography findings, and conservative management in a 64-year-old man alongside his perspective from onset to treatment.

👉 https://t.co/CxEltWmlvI

#CardioTwitter

[Springer Medicine @Springer_Med]

#MedNews - Retatrutide significantly reduces obstructive sleep apnea severity versus placebo in people with overweight or obesity, irrespective of their #type2diabetes status.

Full story 👇
https://t.co/1CxbULZtJO

[Springer Medicine @Springer_Med]

What antidiabetic medications are in the pipeline?

This overview takes a look at the treatments in development, from those in late-stage phase 3 clinical trials through to promising agents in preclinical stages.

👉 https://t.co/7U0zDUde1p

#Diabetes

[Springer Medicine @Springer_Med]

Patients with #type1diabetes have a higher lifetime risk for #CVD, supporting a life-course approach to risk management, yet most do not meet risk factor targets.

From risk prediction to management, this review outlines what to consider 👉 https://t.co/Zl7RPbPWX2

#CardioTwitter

[Springer Medicine @Springer_Med]

From #UEGWeek2026 - Prof. Axel Dignass outlines the latest recommendations published in the STRIDE-III #IBD treatment target guidance.

Watch the full interview 👉️ https://t.co/UGzkmvs9tA

#GITwitter

[Springer Medicine @Springer_Med]

From #ESMO2026 - Dr. James Harding shares a few key hepatobiliary cancer studies before taking a deep dive into the HARMONi-GI1 trial of first-line ivonescimab plus chemotherapy in advanced biliary tract cancer.

Watch the full interview 👉️ https://t.co/O6rTtn7jrG

[Springer Medicine @Springer_Med]

From #ESMO2026 - The HER2-targeted bispecific antibody anbenitamab plus albumin-bound docetaxel shows potential for the first-line treatment of HER2-positive advanced #BreastCancer.

Full story 👉️ https://t.co/zKtFjZkajw

#MedNews

[Springer Medicine @Springer_Med]

From #UEGWeek2026 - Dr. Carlo Senore discusses the latest screening recommendations from the European Commission Initiative on Colorectal Cancer, outlining the key eligibility criteria and modalities.

Watch the full video 👉️ https://t.co/DAIYwZH5Qw

#GITwitter

[Springer Medicine @Springer_Med]

From #ESMO2026 - The next-generation KRAS G12C inhibitor divarasib represents a new standard of care for previously treated, advanced KRAS G12C-mutated #NSCLC.

Full story 👉️ https://t.co/sRfU61WjBt

#MedNews

[Springer Medicine @Springer_Med]

From #ESMO2026 - Among people with previously treated, CLDN18.2-positive, advanced gastroesophageal cancer, treatment with sonesitatug vedotin significantly extends overall survival.

Full story 👉️ https://t.co/IY1QX9eTcj

#MedNews #OncTwitter

[Springer Medicine @Springer_Med]

From #ESMO2026 - Patients with stage IIB–IV cutaneous melanoma derive a significant recurrence-free survival benefit from adding a personalized mRNA-based #CancerVaccine to adjuvant pembrolizumab.

Full story 👉️ https://t.co/qs9PaqIXkF

#MedNews

[Springer Medicine @Springer_Med]

Charcot neuro-osteoarthropathy is a limb-threatening yet under-recognized complication of #diabetes.

Gaps in understanding of susceptibility, pathogenesis, diagnosis, remission, and treatment need to be addressed to improve outcomes.

👉️https://t.co/yczKPB3PtX

#NeuroTwitter

[Springer Medicine @Springer_Med]

#Obesity may worsen #migraine frequency, severity, and disability.

Explore shared biological mechanisms and evolving management approaches, from lifestyle interventions to CGRP-targeted therapies and GLP-1 receptor agonists.

👉️ https://t.co/3g9frDqKIE

#NeuroTwitter